Is L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid? Is L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid safe for nursing mother and child? Does L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid extracts into breast milk? Does L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid has any long term or short term side effects on infants? Can L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid influence milk supply or can L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid decrease milk supply in lactating mothers?
L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid lactation summary
- DrLact safety Score for L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid usage in lactation
When associated to levodopa it may decrease breast milk production.
Alternate Drugs for Anti-parkinson drugs: Anticholinergics & Dopaminergic agents. ATC N04
Amantadine(Low Risk)
Bromocriptine(Unsafe)
Levodopa(Unsafe)
Ropinirole(Unsafe)
Pramipexole(Unsafe)
Amantadine Hydrochloride(Low Risk)
Apomorphine-Hydrochloride(Low Risk)
Biperiden(Unsafe)
Bromocriptine Mesilate(Unsafe)
Carbidopa(Low Risk)
Orphenadrine(Low Risk)
Procyclidine(Unsafe)
Rasagiline(Dangerous)
Ropinirole Hydrochloride(Unsafe)
Orphenadrine Citrate(Low Risk)
L-Dopa(Unsafe)